Core Viewpoint - The third China International Supply Chain Promotion Expo showcases the innovative achievements of Furuida, a subsidiary of Lushang Group, focusing on the integration of traditional Chinese medicine and synthetic biology in the beauty and health industry [1] Group 1: Product Innovation - Furuida presented a full-chain innovation from traditional Chinese medicine extraction to end products, highlighting the "green journey" of ingredients like Centella Asiatica to anti-aging serums [3] - The company integrates traditional Chinese medicine with artificial intelligence for precise control in the production of sensitive skin series products, exemplifying a new paradigm of "green intelligent manufacturing" [3] - The MatrixColla-1 product utilizes a precise ratio of type III recombinant collagen, elastin, and fibronectin to simulate the extracellular matrix structure of the dermis, providing comprehensive anti-aging benefits [4] Group 2: Sustainable Practices - Furuida's green supply chain initiatives include biodegradable packaging that reduces degradation time by 60%, with traditional PE bottles taking 450 years to decompose compared to 180 days for plant-based packaging [5] - The company’s raw materials, such as dihydroxyphenethyl alcohol and sodium hyaluronate, are certified by EU ECOCERT, and their bio-fermentation process reduces emissions by 35% compared to traditional chemical methods [5] Group 3: Research and Development Ecosystem - The innovation ecosystem of Lushang Group combines research institutes, corporate R&D centers, and industrial bases, enhancing the transformation of scientific research into products [7] - Furuida has led or participated in the formulation of over 80 national and industry standards and holds 434 valid patents, including 189 invention patents [7] - The company aims to continue promoting sustainable "Chinese solutions" in the global market, leveraging modernization of traditional Chinese medicine and synthetic biology [7]

Group 1 - The recent leadership change at Unilever (China) Co., Ltd. reflects the company's strategic adjustments in response to challenges in the global and Chinese markets [1][3] - Roland Polaroid Hutabarat has been appointed as the new chairman, succeeding Zhong Zhaomin, indicating Unilever's focus on the beauty and health sectors in China [1][3] - The leadership transition is part of a broader trend of management changes within Unilever globally, aimed at driving business transformation and enhancing profitability [3] Group 2 - Unilever faces significant challenges in the Chinese market, including a high single-digit decline in performance during Q1 2025, with brands like Clear and Lifebuoy experiencing downturns [4] - The rise of local brands poses a strong competitive threat to Unilever, as these brands leverage their understanding of the local market and offer more competitive pricing [4] - Rapid changes in consumer demand are increasing the pressure on Unilever to innovate its product offerings [4] Group 3 - In response to market challenges, Unilever is intensifying its investment in the Chinese market, particularly in the beauty and health sectors, by establishing a high-end beauty matrix with ten major brands [6] - The company is optimizing its brand portfolio by discontinuing underperforming brands, such as Tatcha and REN, to focus resources on stronger brands [6] - Unilever's strategic adjustments aim to enhance market competitiveness and operational efficiency in China [6] Group 4 - The leadership change is seen as a crucial part of Unilever's strategy to address market challenges and signals the company's long-term commitment to the Chinese market [7] - The new chairman's extensive supply chain management experience is expected to improve operational efficiency, particularly in the beauty and health sectors [7] - Unilever's ongoing adjustments and new management are anticipated to bring fresh energy and opportunities in the Chinese market [9]